The store will not work correctly when cookies are disabled.
N-(Cyclopentyl(phenyl)methyl)-2-(1H-imidazol-1-yl)-N-methylacetamide
ID: ALA5084092
PubChem CID: 166627921
Max Phase: Preclinical
Molecular Formula: C18H23N3O
Molecular Weight: 297.40
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CN(C(=O)Cn1ccnc1)C(c1ccccc1)C1CCCC1
Standard InChI: InChI=1S/C18H23N3O/c1-20(17(22)13-21-12-11-19-14-21)18(16-9-5-6-10-16)15-7-3-2-4-8-15/h2-4,7-8,11-12,14,16,18H,5-6,9-10,13H2,1H3
Standard InChI Key: KPKIISUDIQHZHT-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 24 0 0 0 0 0 0 0 0999 V2000
22.1054 -9.3688 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.8131 -8.9478 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.3977 -8.9478 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.6900 -9.3688 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.3977 -8.1100 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
23.5618 -9.2894 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.1086 -8.6697 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.7000 -7.9414 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.9007 -8.1155 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.9823 -8.9478 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2746 -9.3688 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5676 -8.9445 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8603 -9.3648 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8599 -10.1994 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5726 -10.6202 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2769 -10.1976 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.6900 -10.1860 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.9823 -8.1306 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.6386 -7.6482 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.3861 -6.8710 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5688 -6.8710 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3164 -7.6482 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 3 1 0
3 4 1 0
3 5 2 0
2 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 2 1 0
4 10 1 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
4 17 1 0
10 18 1 0
18 19 1 0
19 20 1 0
20 21 1 0
21 22 1 0
22 18 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 297.40 | Molecular Weight (Monoisotopic): 297.1841 | AlogP: 3.27 | #Rotatable Bonds: 5 |
Polar Surface Area: 38.13 | Molecular Species: NEUTRAL | HBA: 3 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 6.72 | CX LogP: 2.65 | CX LogD: 2.59 |
Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.85 | Np Likeness Score: -0.91 |
References
1. Fallica AN, Sorrenti V, D'Amico AG, Salerno L, Romeo G, Intagliata S, Consoli V, Floresta G, Rescifina A, D'Agata V, Vanella L, Pittalà V.. (2021) Discovery of Novel Acetamide-Based Heme Oxygenase-1 Inhibitors with Potent In Vitro Antiproliferative Activity., 64 (18.0): [PMID:34472337] [10.1021/acs.jmedchem.1c00633] |